Appendix 6 (continued)
WwBc*

(x1073)
Postexposure Day

Neutrophils

Lymphocytes

(x1073)

Placeleca**

(x1073)

«<5

Male
<10

Male
>10

Female
All Ages

RBC

z

Total
Group

Male
<15

«<5

>5

<5

>§

3

6.0

7.0

3.0

5.0

2.8

2.2

wore

meee

----

----

wore

7

5.5

6.8

oo

oes

oe

Saeed

oe

----

core

10

6.3

7.3

4.2

4.2

1.9

2.2

22.5

22.6

20.9

21.5

----

(>)

>$

Hematocric,

(x1074)

Male
>15

(x1076)

Female
All Ages

Maile
<15

Male
>15

Female
All Agea

nae

----

tere

a-o--

—--

0

----

wre

one

----

----

--~-

_—--

----

ones
-o-+

Adlingnae Group (69 rads; 18 people plus one in utero)

12

6.3

7.6

1.8

4.7

3.1

2.2

----

_—

-——

ooo

=

----

oso

—--

wa--

15

7.100

74.0

2.3.

4.5

4.2

2.2.

29.0

20.2

24.6

23.9

sere

aes

----

w---

----

----

18

6.8

7.8

2.9

5.0

3.5

2.4

27.5

21.7

24.9

24.3

-oo-

--

-

_--

woe

----

22

8.9

8.7

5.3

5.4

2.7

2.9

23.5

17.0

22.9

21.3

37.5

43.7

39.2

—H-

wooo

----

26

8.4

7.0

4.8

4.4

3.2

2.2

20.0

13.8

17.4

16.7

36.5

43.2

36.8

—--

eo

—---

30

9.6

8.6

5.3

6.2

3.7

2.0

19.5

12.8

18.2

16.8

36.0

44.6

36.7

-—--

woo

ee

33

7.7?

7.B

3.3

5.2

3.5

2.2

24.0

15.8

22.7

17.6

35.5

43.8

37.3

----

----

cece

39

7.5

6.2

2.9

4.2

4.7

1.9

26.5

20.8

27.0

25.2

35.0

45.6

37.4

—~-

—--

~---

43

6.9

6.5

2.7

3.6

3.9

2.7

28.0

19.6

25.3

24.0

36.0

45.2

36.8

—<-

~o--

wote

47

7.3

6.7

3.5

3.8

3.4

2.7

27.0

20.0

26.1

24.5

----

46.5

40.2

_—--

~---

sere

51

8.4

6.3

3.8

3.6

4.0

2.2

32.0

18.2

25.0

23.9

wees

meee

----

eo

seer

-——

54

4.6

6.3

2.86

3.5

3.2.

2.5

37.0

19.8

23.8

24.2

weet

oseoe

—---

see

neon

----

6-mo survey

7.7

6.5

4.8

3.9

2.7)

2.2

25.2

19.2

23.9

22.7

37.5

40.2

37.3

aoe

ee’

----

leyr survey

lll

7.8

4.2.

4.7

6.5

5.6

38.7

21.4

28.3

27.5

33.0

44.6

36.2

le

ao--

2-yr survey

11.0

9.1

4.9

S.1

4.8

3.2

51.2

17.4

26.4

26.7

35.7

44.4

37.5

a

eee

----

i-yr survey

12.1

7.0

5.5

3.9

5.6

2.6

40.8

22.4

31.2

_--

37.5

40.6

35.6

—-

Oo

oo--

4-yt survey

11.5

7.5

2.8

3.7

7.0

3.3

33.2

24.7

33.6

---

36.8

43.1

35.7

mer

oe

-—--

S-yr survey

--—-

869.7

~~

5.1

---

3.7

40.9

26.3

26.8

_-

coer

tee

-—

4.46

5.15

4.31

6-yr survey

wo--

73

---

3.6

---

63.0

—_

----

soon

tee

atteted

---

mee

sen

----

7-yr survey

-_——-

7.7

—

4.1

-—

3.1

<co-

25.6

28.1

—--<

36.0

44.2

37.0

4.56

5.11

4.19

8-yr survey

----

6.5

---

3.4

---

2.6

——

=—33.4

32.7

sore

37.0

42.5

37.8

4.51

5.12

4.35

S-yr survey

a

71

---

4.0

---

2.4

----

23.5

23.6

“ee

36.0

44.0

38.3

3.77)

4.69

4.10

l0-yr survey

—-—

7.5

---

3.6

---

3.1

oo

32.4

41.5

----

37.0

43.0

38.3

soot

roe

----

ll-yr survey

a—--

67.1

---

3.8

-—-

2.7

oom

33.5

34.7

—--

37.5

46.0

37.6

4.33

5.09

4.11

l2-yr survey

-_

6.2

-—_

3.3

-_—

2.3

—_—

—_—_

=

----

38.5

44.2

37.8

---

oon

----

l3-yr survey

——

«6.4

---

3.0

-—-

2.9

----

20.7

22.8

ooo

36.0

43.6

36.5

3.84

4.98

4.146

l4-yr survey

--—-

55.6

---

3.8

---

2.2

———

--—

-—---

38.0

46.5

39.3

ee

coos

15-yr survey

----

5.8

---

3.2

w--

2.2

awom-

17.2

21.4

---~

w---

45.0

35.6

——--

4.67

3.59

l6-yr survey

----

6.4

-—-

84.0

=--

=—2.0

woe

lee

---

>

----

40.6

38.0

es

oe

ccee

l7-yr survey

~——-

«6.7

-—

3.4

“—~

862.6

----

17.2

28.46

---

wo--

434

35.5

—--

4.33

3.82

18-yr survey

a--

745

w--

4.6

-—

2.2

ao--

(19.5

33.0

~<--

won-

42.5

35.5

—--

65.01

4,29

19-yr survey Mar

----

7.1

—-

3.7

---

2.3

—---

24.0

25.1

vere

----

(38.7

38.6

a--

4.54

4.11

19-yr survey Sep

ao

71

---

6349

~—

2.2

-——-

24.1

26.2

-—---

wore

42,1

38.9

w=

=4.92

4.55

20-yr survey Mar

----

7.8.

—-

4.6

-—-

2.0

——

24.9

30.1

—--

awwo-

44.4

35.2

----

6.30

4.34

20-yr survey Sep

-——~

6.6

-—

63.4

---

2.4

-om~

17.2

19.8

—--

aewn=

50.6

40.4

——--

5.64

4.50

- 108 -

Select target paragraph3